Lakewood Capital Still Shorting Pot Stocks, Korean Biotech – ValueWalk Premium

Lakewood Capital Still Shorting Pot Stocks, Korean Biotech

The end of 2018 brought a return to reality in the form of a steep bear market for equities. Of course, it created a nearly impossible situation for many funds on the long side, but it was actually good news for some short-sellers. Lakewood Capital was one of those which managed to capitalize on the tumbling stock market through several key short positions.

Q4 hedge fund letters, conference, scoops etc

Lakewood Capital sees strong returns on shorts
Reputable short-seller Anthony Bozza said in his annual letter for the fund that their short positions generated a return of 34% for the fourth quarter. However, the strong results from their short portfolio toward the end of the year have them treading lightly now.

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds.   

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

SIGN UP NOW
0